These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12770993)

  • 1. Successful photodynamic therapy for subretinal neovascularisation due to Sorsby's fundus dystrophy: 1 year follow up.
    Wong SC; Fong KC; Lee N; Gregory-Evans K; Gregory-Evans CY
    Br J Ophthalmol; 2003 Jun; 87(6):796-7. PubMed ID: 12770993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical notes during photodynamic therapy for subretinal neovascularization].
    Zolotarev AV; Malyshev AS; Fadeeva AV; Morozova IuV
    Vestn Oftalmol; 2007; 123(6):43-6. PubMed ID: 18225527
    [No Abstract]   [Full Text] [Related]  

  • 3. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
    Potter MJ; Szabo SM; Chan EY; Morris AH
    Am J Ophthalmol; 2002 Jan; 133(1):149-51. PubMed ID: 11755857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.
    Potter MJ; Szabo SM; Sarraf D; Michels R; Schmidt-Erfurth U
    Can J Ophthalmol; 2006 Feb; 41(1):34-7. PubMed ID: 16462869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
    Bressler NM; Bressler SB
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
    [No Abstract]   [Full Text] [Related]  

  • 7. Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis.
    Hershberger VS; Hutchins RK; Laber PW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):318-20. PubMed ID: 12875464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent choroidal thickening despite photodynamic therapy for circumscribed choroidal hemangioma.
    Hussain N; Das T; Ram LS; Sumasri K
    Ophthalmic Surg Lasers Imaging; 2006; 37(1):76-8. PubMed ID: 16468558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
    Gibson J
    Eye (Lond); 2005 Aug; 19(8):829-30. PubMed ID: 16086038
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
    Sivaprasad S; Patra S; DaCosta J; Adewoyin T; Shona O; Pearce E; Chong NV
    Ophthalmologica; 2011; 225(4):200-6. PubMed ID: 21293163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin.
    Silva R; Torrent T; Loureiro R; Travassos A; de Abreu JR
    Eur J Ophthalmol; 2004; 14(5):434-7. PubMed ID: 15506607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy: observation versus photodynamic therapy.
    Viola F; Villani E; Mapelli C; Staurenghi G; Ratiglia R
    J Pediatr Ophthalmol Strabismus; 2010; 47(2):121-2. PubMed ID: 20349908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
    Soubrane G; Bressler NM
    Br J Ophthalmol; 2001 Apr; 85(4):483-95. PubMed ID: 11264143
    [No Abstract]   [Full Text] [Related]  

  • 14. [Photodynamic therapy carefully destroys neovascularization of the retina].
    Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of peripapillary choroidal neovascularisation.
    Postelmans L; Coquelet P; Verougstraete C; Willermain F
    Br J Ophthalmol; 2008 May; 92(5):721-2. PubMed ID: 18441186
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease.
    Nóbrega M; Bortolotto C; Farah M
    Can J Ophthalmol; 2007 Oct; 42(5):761-2. PubMed ID: 17891211
    [No Abstract]   [Full Text] [Related]  

  • 17. Photodynamic therapy with verteporfin in paediatric and young adult patients: long-term treatment results of choroidal neovascularisations.
    Lipski A; Bornfeld N; Jurklies B
    Br J Ophthalmol; 2008 May; 92(5):655-60. PubMed ID: 18356263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy with visudyne: criteria for treatment success].
    Izmaĭlov AS; Balashevich LI
    Vestn Oftalmol; 2007; 123(6):17-21. PubMed ID: 18225518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
    Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
    Montero JA; Ruiz-Moreno JM
    Br J Ophthalmol; 2003 Feb; 87(2):173-6. PubMed ID: 12543746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.